Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go

Gevaert T, Cimadamore A, Eckstein M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R (2019)

Publication Type: Journal article, Review article

Publication year: 2019

Journal

Future Oncology Future Medicine Ltd

Book Volume: 15

Pages Range: 2199-2202

Journal Issue: 19

DOI: 10.2217/fon-2019-0217

Authors with CRIS profile

Markus Eckstein Institute of Pathology

Involved external institutions

Università Politecnica delle Marche (UNIVPM) / Marche Polytechnic University

Italy (IT) University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Belgium (BE) University of Cordoba / Universidad de Córdoba (UCO)

Spain (ES) Indiana University – Purdue University Indianapolis

United States (USA) (US)

How to cite

APA:

Gevaert, T., Cimadamore, A., Eckstein, M., Scarpelli, M., Lopez-Beltran, A., Cheng, L., & Montironi, R. (2019). Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go. Future Oncology, 15(19), 2199-2202. https://dx.doi.org/10.2217/fon-2019-0217

MLA:

Gevaert, Thomas, et al. "Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go." Future Oncology 15.19 (2019): 2199-2202.

BibTeX: Download